Literature DB >> 1822762

Autonomic involvement in extrapyramidal and cerebellar disorders.

P Sandroni1, J E Ahlskog, R D Fealey, P A Low.   

Abstract

We reviewed the clinical and autonomic features of all patients with extrapyramidal and cerebellar disorders studied in the Mayo Autonomic Reflex Laboratory from 1983 to 1989. Patients were grouped into the following categories (number in parentheses): Parkinson's disease (35); parkinsonism-plus (54); multiple system atrophy (75); hereditary multisystem degenerations (eleven); progressive supranuclear palsy (32); non-familial cerebellar degeneration (eleven); nonspecific sporadic multisystem degeneration (73). Severe autonomic failure occurred in 97% of patients with multiple system atrophy and 53% of the nonspecific sporadic multisystem degeneration patients respectively. Autonomic involvement was mild or absent in Parkinson's disease while parkinsonism-plus and non-familial cerebellar degeneration patients had moderate autonomic failure. Orthostatic blood pressure reduction, percentage of anhidrosis on thermoregulatory sweat test, quantitative sudomotor axon reflex test, forearm response and heart rate response to deep breathing strongly regressed with severity. A response to levodopa treatment in patients with parkinsonism was more likely if cerebellar signs and cognitive deficits were absent. The presence of levodopa induced dyskinesia was also a marker for a clinically favourable levodopa response. We conclude that there is a spectrum of autonomic involvement in these degenerative disorders and that autonomic studies are useful in separating them and monitoring their course.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1822762     DOI: 10.1007/BF01826212

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  25 in total

1.  Splanchnic preganglionic neurons in man. I. Morphometry of preganglionic cytons.

Authors:  P A Low; H Okazaki; P J Dyck
Journal:  Acta Neuropathol       Date:  1977-09-26       Impact factor: 17.088

2.  L-dopa and the Shy-Drager syndrome.

Authors:  J A Steiner; P A Low; C Y Huang; M West; J B Uther; J L Allsop; J P Chalmers
Journal:  Med J Aust       Date:  1974-07-27       Impact factor: 7.738

3.  Autonomic deficits in Parkinson's syndrome.

Authors:  O Appenzeller; J E Goss
Journal:  Arch Neurol       Date:  1971-01

4.  Autonomic dysfunction in Parkinson's disease.

Authors:  C G Goetz; W Lutge; C M Tanner
Journal:  Neurology       Date:  1986-01       Impact factor: 9.910

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa-decarboxylase inhibition.

Authors:  C Sachs; B Berglund; L Kaijser
Journal:  Acta Neurol Scand       Date:  1985-01       Impact factor: 3.209

7.  Assessment of autonomic function in patients with a Parkinsonian syndrome.

Authors:  M J Aminoff; C S Wilcox
Journal:  Br Med J       Date:  1971-10-09

8.  Dysautonomia in Parkinsonism: a clinicopathological study.

Authors:  A H Rajput; B Rozdilsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-11       Impact factor: 10.154

9.  Postprandial and orthostatic hypotension in Parkinson's disease.

Authors:  G Micieli; E Martignoni; A Cavallini; G Sandrini; G Nappi
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

10.  Hypotension caused by L-dopa.

Authors:  D B Calne; J Brennan; A S Spiers; G M Stern
Journal:  Br Med J       Date:  1970-02-21
View more
  27 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Prevalence of orthostatic hypotension.

Authors:  Phillip A Low
Journal:  Clin Auton Res       Date:  2008-03-27       Impact factor: 4.435

Review 3.  Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American Academy of Neurology.

Authors:  S Gilman; P Low; N Quinn; A Albanese; Y Ben-Shlomo; C Fowler; H Kaufmann; T Klockgether; A Lang; P Lantos; I Litvan; C Mathias; E Oliver; D Robertson; I Schatz; G Wenning
Journal:  Clin Auton Res       Date:  1998-12       Impact factor: 4.435

4.  Vasomotor regulation in patients with multiple system atrophy.

Authors:  Kazumasa Shindo; Mai Tsuchiya; Yuta Ichinose; Kishin Koh; Takanori Hata; Nobuo Yamashiro; Fumikazu Kobayashi; Takamura Nagasaka; Yoshihisa Takiyama
Journal:  J Neural Transm (Vienna)       Date:  2016-11-08       Impact factor: 3.575

5.  The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy.

Authors:  Kurt Kimpinski; Valeria Iodice; Duane D Burton; Michael Camilleri; Brian P Mullan; Axel Lipp; Paola Sandroni; Tonette L Gehrking; David M Sletten; J E Ahlskog; Robert D Fealey; Wolfgang Singer; Phillip A Low
Journal:  J Neurol Sci       Date:  2012-03-14       Impact factor: 3.181

Review 6.  Preventing and treating orthostatic hypotension: As easy as A, B, C.

Authors:  Juan J Figueroa; Jeffrey R Basford; Phillip A Low
Journal:  Cleve Clin J Med       Date:  2010-05       Impact factor: 2.321

Review 7.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

8.  The classification and nomenclature of autonomic disorders--ending chaos, resolving conflict and hopefully achieving clarity.

Authors:  C J Mathias
Journal:  Clin Auton Res       Date:  1995-12       Impact factor: 4.435

9.  Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variability.

Authors:  C Brefel-Courbon; C Thalamas; O Rascol; J L Montastruc; J M Senard
Journal:  Clin Auton Res       Date:  2000-10       Impact factor: 4.435

10.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.